BNP Paribas Financial Markets Invests $50,000 in Grail, Inc. (NASDAQ:GRAL)

BNP Paribas Financial Markets purchased a new position in shares of Grail, Inc. (NASDAQ:GRAL) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 2,820 shares of the company’s stock, valued at approximately $50,000.

Several other hedge funds and other institutional investors have also modified their holdings of GRAL. Crcm LP acquired a new stake in shares of Grail in the fourth quarter valued at $65,061,000. Primecap Management Co. CA acquired a new stake in shares of Grail in the fourth quarter valued at $37,118,000. Vanguard Group Inc. acquired a new stake in shares of Grail in the fourth quarter valued at $25,902,000. AQR Capital Management LLC acquired a new stake in shares of Grail in the fourth quarter valued at $14,828,000. Finally, Arbiter Partners Capital Management LLC acquired a new stake in shares of Grail in the fourth quarter valued at $14,827,000.

Insider Activity

In other news, President Joshua J. Ofman sold 48,213 shares of the business’s stock in a transaction dated Friday, May 2nd. The stock was sold at an average price of $33.93, for a total value of $1,635,867.09. Following the completion of the sale, the president now directly owns 511,460 shares of the company’s stock, valued at approximately $17,353,837.80. The trade was a 8.61% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Aaron Freidin sold 1,816 shares of the business’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $56,659.20. Following the completion of the sale, the chief financial officer now directly owns 335,170 shares of the company’s stock, valued at $10,457,304. The trade was a 0.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 194,948 shares of company stock valued at $6,583,130. Insiders own 1.85% of the company’s stock.

Grail Stock Performance

GRAL opened at $38.55 on Wednesday. Grail, Inc. has a one year low of $12.33 and a one year high of $63.99. The stock has a market capitalization of $1.39 billion and a P/E ratio of -0.63. The business’s 50-day simple moving average is $32.44 and its 200-day simple moving average is $28.72.

Grail (NASDAQ:GRAL) last posted its earnings results on Tuesday, May 13th. The company reported ($3.10) earnings per share for the quarter, beating the consensus estimate of ($4.03) by $0.93. The firm had revenue of $31.84 million during the quarter, compared to analysts’ expectations of $35.80 million. On average, equities research analysts forecast that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have weighed in on the company. Morgan Stanley raised their price target on Grail from $16.00 to $20.00 and gave the company an “equal weight” rating in a research note on Tuesday, March 18th. Canaccord Genuity Group raised their price target on Grail from $32.00 to $43.00 and gave the company a “buy” rating in a research note on Wednesday, May 14th.

Grail Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.